Andrea F. Wainer - 08 Aug 2023 Form 4 Insider Report for ABBOTT LABORATORIES (ABT)

Signature
/s/ Andrea F. Wainer by Jessica H. Paik, Attorney-in-Fact
Issuer symbol
ABT
Transactions as of
08 Aug 2023
Net transactions value
-$900,297
Form type
4
Filing time
10 Aug 2023, 18:31:43 UTC
Previous filing
03 May 2023
Next filing
18 Dec 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ABT Common shares without par value Options Exercise $192,000 +5,000 +7.1% $38.40 75,427 08 Aug 2023 Direct
transaction ABT Common shares without par value Sale $497,805 -4,741 -6.3% $105.00 70,686 08 Aug 2023 Direct
transaction ABT Common shares without par value Sale $25,725 -244 -0.35% $105.43 70,442 08 Aug 2023 Direct
transaction ABT Common shares without par value Sale $1,611 -15 -0.02% $107.42 70,427 08 Aug 2023 Direct
transaction ABT Common shares without par value Sale $536,760 -5,112 -7.3% $105.00 65,315 08 Aug 2023 Direct
transaction ABT Common shares without par value Sale $28,677 -272 -0.42% $105.43 65,043 08 Aug 2023 Direct
transaction ABT Common shares without par value Sale $1,719 -16 -0.02% $107.42 65,027 08 Aug 2023 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ABT Option (right to buy) Options Exercise $0 -5,000 -100% $0.000000* 0 08 Aug 2023 Common Shares 5,000 $38.40 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.

Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Explanation of Responses:

Id Content
F1 Employee stock option granted pursuant to the Abbott Laboratories 2009 Incentive Stock Program, in a transaction exempt from Section 16 under Rule 16b-3.